Nextel Medical Corp. MAJI
OTC PK
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 12.80K | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 12.80K | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | 12.80K | |||
| SG&A Expenses | 66.90K | 3.10K | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 123.10K | 45.10K | |||
| Operating Income | -123.10K | -32.30K | |||
| Income Before Tax | -373.20K | -32.30K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -373.20K | -32.30K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -373.20K | -32.30K | |||
| EBIT | -123.10K | -32.30K | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00 | 0.00 | |||
| Normalized Basic EPS | 0.00 | 0.00 | |||
| EPS Diluted | 0.00 | 0.00 | |||
| Normalized Diluted EPS | 0.00 | 0.00 | |||
| Average Basic Shares Outstanding | 249.84M | 249.84M | |||
| Average Diluted Shares Outstanding | 249.84M | 249.84M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||